Verrica Pharmaceuticals Inc. Operating Lease Liability
Verrica Pharmaceuticals Inc. (VRCA) had Operating Lease Liability of $416.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability $416.00K.
- 2026-03-31: Operating Lease, Liability $500.00K.
- 2025-12-31: Operating Lease, Liability $583.00K.
- 2025-09-30: Operating Lease, Liability $665.00K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $416.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $583.00K 10-K · filed 2026-03-11 | |
| 2025-09-30 | $665.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $744.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $821.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $898.00K 10-K · filed 2025-03-11 | |
| 2024-09-30 | $980.00K 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $1.08M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.16M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $1.23M 10-K · filed 2024-02-29 | |
| 2023-09-30 | $1.30M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.38M 10-Q · filed 2023-08-08 | |
| 2022-12-31 | $1.53M 10-K · filed 2023-03-06 | |
| 2022-09-30 | $1.59M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $1.66M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.45M 10-Q · filed 2023-05-09 | $1.63M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.69M 10-K · filed 2022-03-02 | |
| 2021-09-30 | $1.75M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.81M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $1.86M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $1.89M 10-K · filed 2021-03-17 | |
| 2020-09-30 | $2.00M 10-Q · filed 2020-11-09 | |
| 2020-09-01 | $1.90M 10-K · filed 2022-03-02 | |
| 2020-06-30 | $124.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $156.00K 10-Q · filed 2020-05-07 | |
| 2020-03-12 | $1.90M 10-Q · filed 2020-11-09 | |
| 2019-12-31 | $188.00K 10-K · filed 2020-03-13 | |
| 2019-09-30 | $218.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $248.00K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $278.00K 10-Q · filed 2019-05-07 | |
| 2019-01-01 | $306.00K 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |